Next generation sequencing aids diagnosis and management in a case of encephalocraniocutaneous lipomatosis
Pediatric Dermatology · 2024-01 · 41 (1) · 76-79
DOI: 10.1111/pde.15353 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Dermatology, online erschienen am 24.07.2023. Verfasst von Kelly K Barry und 5 weiteren Autor:innen. Beteiligte Einrichtung: Tufts University School of Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Neurocutaneous Syndromes, Eye Diseases, Lipomatosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: NIH National Institute of Neurological Disorders and Stroke, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Encephalocraniocutaneous lipomatosis (ECCL) is a rare neurocutaneous disorder caused by somatic FGFR1 and KRAS variants. It shares significant phenotypic overlap with several closely related disorders caused by mutations in the RAS‐MAPK pathway (mosaic RASopathies). We report a diagnostically challenging case of ECCL in which next‐generation sequencing of affected tissue identified a pathologic FGFR1 p.K656E variant, thereby establishing a molecular diagnosis. Patients with FGFR1 ‐associated ECCL carry a risk of developing malignant brain tumors; thus, genetic testing of patients with suspected ECCL has important management implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tufts University School of Medicine, Boston, Massachusetts, USA.
- Department of Dermatology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Plastic & Oral Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Alanna J Church
Förderung
- NIH National Institute of Neurological Disorders and Stroke
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Barry, K. K., Liang, M. G., Balkin, D. M., Srivastava, S., Church, A. J., & Eng, W. (2024). Next generation sequencing aids diagnosis and management in a case of encephalocraniocutaneous lipomatosis. Pediatric Dermatology, 41(1), 76-79. https://doi.org/10.1111/pde.15353
Vancouver
Barry KK, Liang MG, Balkin DM, Srivastava S, Church AJ, Eng W. Next generation sequencing aids diagnosis and management in a case of encephalocraniocutaneous lipomatosis. Pediatric Dermatology. 2024;41(1):76-79. doi:10.1111/pde.15353
BibTeX
@article{Barry2024,
author = {Barry, Kelly K and Liang, Marilyn G and Balkin, Daniel M and Srivastava, Siddharth and Church, Alanna J and Eng, Whitney},
title = {Next generation sequencing aids diagnosis and management in a case of encephalocraniocutaneous lipomatosis},
journal = {Pediatric Dermatology},
year = {2024},
volume = {41},
number = {1},
pages = {76--79},
doi = {10.1111/pde.15353}
}
EUVIMED